1800 244 735

Helpline (02) 9874 9777

Coming Soon: EuroBuzz 2012

Stand by for EuroBuzz – hot-off-the-press Huntington’s disease research news from the European HD Network Meeting in Stockholm, brought to you by HDBuzz.

EHDN 2012

The European Huntington’s Disease Network (EHDN) is a Europe-wide collaboration of HD professionals, researchers and people affected by HD. EHDN exists to encourage sharing information and ideas about HD, studies and possible treatments, throughout Europe and beyond

EHDN 2012, in Stockholm, Sweden, is the 7th meeting of the whole Network. It’s one of the largest gatherings of HD researchers in the world, and this year’s meeting promises to be the biggest and most exciting EHDN conference yet. Nearly a thousand delegates are expected to attend, and over 300 posters and dozens of fascinating and innovative platform talks will be presented – all dedicated to understanding and developing treatments for Huntington’s disease.

The meeting kicks off this Friday, 14th September, and runs until Sunday 16th.

EuroBuzz!

HDBuzz reporters Dr Ed Wild and Dr Jeff Carroll will be bringing you live updates from the meeting, starting at 9am Swedish time (8am BST / 3am EDT) on Friday 14th September. Follow @hdbuzzfeed on Twitter to get the live feed. We’re calling our coverage EuroBuzz 2012.

Each day, all our updates will be brought together at hdbuzz.net as a single news story.

But wait – there’s more

At the end of each day’s science presentations on Friday 14th and Saturday 15th September, Ed and Jeff will take to the stage to interview the top scientists who’ve presented their research at the meeting. We’ll be getting the lowdown directly, and helping our guests to steer clear of jargon and science-speak.

Video of these live sessions will be available shortly afterwards, at hdbuzz.net.

Get involved

We want you to get involved, by sending us questions to ask our expert guests.

Just follow @hdbuzzfeed on Twitter and send us your question as a tweet.

Our confirmed guests so far are:

    n

  • Dr Ray Truant: the huntingtin protein and how it causes damage

  • n

  • Dr Mike Orth: using advanced scanning techniques to detect brain changes before disease onset

  • n

  • Dr Bev Davidson – gene silencing treatments for Huntington’s disease

  • n

  • Dr Lisa Ellerby – stem cells and how they can help fight HD

  • n

Plus we’ll be covering the controversial topic of diagnosing ‘disease onset’ in HD and phosphodiesterase (PDE) inhibitors, a new and exciting possible approach to treating HD symptoms.

You can also see the program for the whole meeting at the EHDN website, euro-hd.net.

We’re looking forward to three days of great science, and we hope you’ll join us for EuroBuzz 2012!

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest Research Articles

Scientists identify precisely how pridopidine works in models of Huntington’s disease

Published date: 12 June, 2021

Pridopidine is a drug developed to treat Huntington’s disease (HD) and now scientists have a clearer understanding of how it works in the body and brain. In a series of academic papers, researchers figured out that pridopidine is working by targeting a particular receptor protein called S1R. With this new understanding, the researchers believe pridopidine ... Read more

Huntington's disease therapeutics conference 2021 – Day 3

Published date: 29 April, 2021

We are back for the last day of the virtual 2021 CHDI Therapeutics conference. This article summarises our live Twitter updates on the exciting science being presented, which you can find with the hashtag #HDTC2021. The final session of the conference will provide the latest news on more Huntington’s disease clinical programs. A new way ... Read more

Huntington's disease therapeutics conference 2021 – Day 2

Published date: 28 April, 2021

We are back with Day 2 of the virtual 2021 CHDI Therapeutics conference. This article summarises our live Twitter updates on the exciting science being presented, which you can continue to follow with the hashtag #HDTC2021. The morning session focussed on promising HD therapeutics that are in preclinical development and the afternoon session covered different ... Read more

Huntington’s disease therapeutics conference 2021 – Day 1

Published date: 28 April, 2021

The CHDI Therapeutics Conference 2021 kicked off today. This article summarizes our live Twitter updates on the exciting science being presented, which you can continue to follow with the hashtag #HDTC2021. The morning of Day 1 focused on clinical trial updates, while the afternoon explored genetic modifiers of HD and how they might be harnessed ... Read more

Huntington’s disease clinical trial round up

Published date: 26 April, 2021

It seems like the HD community has been inundated with updates from different companies and clinical trials recently. The news is far from complete doom and gloom; although there have been some real disappointments from some of the frontrunner trials, there are also positive updates from many different companies and lots of reasons for us ... Read more

Good news from uniQure: gene therapy trial on track, and promising data in animals

Published date: 15 April, 2021

Two recent press releases from uniQure provide welcome good news: the first ever HD gene therapy, known as AMT-130, has been administered via brain surgery to a small set of participants in an early safety trial. At the same time, uniQure has published findings in HD animal models that increase confidence in the drug’s ability ... Read more